Immatics’ cell therapy has been linked to a 56% objective response rate (ORR) among 32 heavily pretreated patients with ...

The next phase of testing is set to begin for NASA's crewed Artemis program, which aims to return humans to the moon, the ...

The market is expected to consolidate after the two-day rally and may attempt another session of upward movement. Below are ...